Literature DB >> 13595494

In vitro and pharmacological studies with kanamycin.

H WELCH, W W WRIGHT, H I WEINSTEIN, A W STAFFA.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; ANTIBIOTICS/effects

Mesh:

Substances:

Year:  1958        PMID: 13595494     DOI: 10.1111/j.1749-6632.1958.tb54693.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  [In vitro sensitivity of enterococci to the usual antibiotics].

Authors:  D GROESCHEL; G PULVERER
Journal:  Z Hyg Infektionskr       Date:  1962

2.  [Bacteriological studies on kanamycin].

Authors:  S HAUCK
Journal:  Z Hyg Infektionskr       Date:  1960

3.  [Sensitivity of 231 gram-positive and gram-negative pathogenic microorganisms to kanamycin].

Authors:  G K DAIKOS; M ATHANASIADOU; E DELIGEORGI
Journal:  Z Hyg Infektionskr       Date:  1960

4.  Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.

Authors:  C M KUNIN; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  Serum protein binding of the aminoglycoside antibiotics.

Authors:  R C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

6.  Cerebrospinal fluid diffusion of kanamycin in newborn infants.

Authors:  L L McDonald; J W St Geme
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191

7.  Use of a digital computer programme as a guide to the prescribing of kanamycin in patients with renal insufficiency.

Authors:  B R Knowles; S B Lucas; G E Mawer; R M Stirland; J A Tooth
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

8.  Pleiotropic antibiotic resistance mutations associated with ribosomes and ribosomal subunits in Mycobacterium smegmatis.

Authors:  T Yamada; K Masuda; K Shoji; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.